{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:04:47Z","timestamp":1793192687456,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 MH102374"],"award-info":[{"award-number":["R21 MH102374"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["261895"],"award-info":[{"award-number":["261895"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bbi.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T21:47:00Z","timestamp":1683236820000},"page":"270-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals"],"prefix":"10.1016","volume":"111","author":[{"given":"Pablo","family":"Le\u00f3n-Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Rivera-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiram","family":"Torres-Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Reyes-Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Carrillo-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Moncada-Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Cassiano-Quezada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin S.","family":"Cadenhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"G\u00f3mez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbi.2023.05.001_b0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ahj.2010.06.006","article-title":"Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers","volume":"160","author":"Asthana","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbi.2023.05.001_b0010","first-page":"262","article-title":"Alteration of serum levels of cytokines in schizophrenic patients before and after treatment with risperidone","volume":"18","author":"Azizi","year":"2019","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"51","key":"10.1016\/j.bbi.2023.05.001_b0015","doi-asserted-by":"crossref","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","article-title":"Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia","volume":"28","author":"Behrens","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2023.05.001_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41398-020-0700-6","article-title":"Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients","volume":"10","author":"Birur","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.001_b0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.biopsych.2020.06.027","article-title":"Associations Between cognitive function and levels of glutamatergic metabolites and gamma-aminobutyric acid in antipsychotic-naive patients with schizophrenia or psychosis","volume":"89","author":"Bojesen","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"18","key":"10.1016\/j.bbi.2023.05.001_b0030","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1523\/JNEUROSCI.5276-03.2004","article-title":"CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation","volume":"24","author":"Byram","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2023.05.001_b0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0278-5846(01)00221-4","article-title":"Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study","volume":"26","author":"Cazzullo","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2023.05.001_b0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0004867419898520","article-title":"Neurochemical and brain functional changes in the ventromedial prefrontal cortex of first-episode psychosis patients: A combined functional magnetic resonance imaging-proton magnetic resonance spectroscopy study","volume":"54","author":"Cen","year":"2020","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.05.001_b0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","article-title":"Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain","volume":"8","author":"Chang","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2023.05.001_b0050","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1212\/WNL.0000000000000526","article-title":"Effects of APOE epsilon4, age, and HIV on glial metabolites and cognitive deficits","volume":"82","author":"Chang","year":"2014","journal-title":"Neurology"},{"issue":"1-3","key":"10.1016\/j.bbi.2023.05.001_b0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2014.12.026","article-title":"The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia","volume":"167","author":"Cohen","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2023.05.001_b0060","doi-asserted-by":"crossref","first-page":"100330","DOI":"10.1016\/j.bbih.2021.100330","article-title":"T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives","volume":"17","author":"Corsi-Zuelli","year":"2021","journal-title":"Brain Behav Immun Health"},{"issue":"7","key":"10.1016\/j.bbi.2023.05.001_b0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S2215-0366(22)00121-3","article-title":"The enduring gap in educational attainment in schizophrenia according to the past 50 years of published research: a systematic review and meta-analysis","volume":"9","author":"Crossley","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.001_b0070","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbi.2023.05.001_b0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","article-title":"Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study","volume":"70","author":"de la Fuente-Sandoval","year":"2013","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2023.05.001_b0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2017.09.028","article-title":"Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients","volume":"83","author":"de la Fuente-Sandoval","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"24","key":"10.1016\/j.bbi.2023.05.001_b0085","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1523\/JNEUROSCI.4402-15.2016","article-title":"Large-scale meta-analysis of human medial frontal cortex reveals tripartite functional organization","volume":"36","author":"de la Vega","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2023.05.001_b0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jns.2016.10.052","article-title":"Hippocampal adult neurogenesis: Does the immune system matter?","volume":"372","author":"de Miranda","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"1-3","key":"10.1016\/j.bbi.2023.05.001_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2014.02.005","article-title":"Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment","volume":"154","author":"de Witte","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2023.05.001_b0100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1017\/S1461145710001653","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"14","author":"Drexhage","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2023.05.001_b0105","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.3748\/wjg.v12.i38.6098","article-title":"Heavy smoking and liver","volume":"12","author":"El-Zayadi","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbi.2023.05.001_b0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2013.11.006","article-title":"Inflammation and the two-hit hypothesis of schizophrenia","volume":"38","author":"Feigenson","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2023.05.001_b0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/schbul\/sbt001","article-title":"Pro-\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia","volume":"40","author":"Garcia-Bueno","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.bbi.2023.05.001_b0120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mrm.20901","article-title":"Use of tissue water as a concentration reference for proton spectroscopic imaging","volume":"55","author":"Gasparovic","year":"2006","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bbi.2023.05.001_b0125","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.npp.1300446","article-title":"Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development","volume":"29","author":"Gilmore","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2023.05.001_b0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbi.2018.11.315","article-title":"Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis","volume":"76","author":"Goldsmith","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.05.001_b0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.001_b0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"issue":"2-3","key":"10.1016\/j.bbi.2023.05.001_b0145","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2015.04.004","article-title":"Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls","volume":"165","author":"Hope","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2023.05.001_b0150","doi-asserted-by":"crossref","first-page":"100038","DOI":"10.1016\/j.bbih.2020.100038","article-title":"Overlapping evidence of innate immune dysfunction in psychotic and affective disorders","volume":"2","author":"Hughes","year":"2020","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.001_b0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mrm.10481","article-title":"Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis","volume":"50","author":"Inglese","year":"2003","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bbi.2023.05.001_b0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pnpbp.2018.03.016","article-title":"Neurometabolite levels in antipsychotic-naive\/free patients with schizophrenia: A systematic review and meta-analysis of (1)H-MRS studies","volume":"86","author":"Iwata","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2023.05.001_b0165","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/CDLI.8.6.1097-1103.2001","article-title":"Comparison of serum and cell-specific cytokines in humans","volume":"8","author":"Jason","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.bbi.2023.05.001_b0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","article-title":"Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions","volume":"78","author":"Javitt","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbi.2023.05.001_b0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajp.2017.01.026","article-title":"Cytokines, cortisol and IGF-1 in first episode psychosis and ultra high risk males. Evidence for TNF-alpha, IFN-gamma, TauNF-beta, IL-4 deviation","volume":"26","author":"Karanikas","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.bbi.2023.05.001_b0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archgenpsychiatry.2011.1519","article-title":"Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy","volume":"69","author":"Kegeles","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.001_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2020.01.003","article-title":"Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness","volume":"226","author":"Kelsven","year":"2020","journal-title":"Schizophr. Res."},{"issue":"21","key":"10.1016\/j.bbi.2023.05.001_b0190","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.0402268101","article-title":"T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions","volume":"101","author":"Kipnis","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2023.05.001_b0195","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbi.2018.09.016","article-title":"Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function","volume":"74","author":"Kogan","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"2-3","key":"10.1016\/j.bbi.2023.05.001_b0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pscychresns.2012.02.003","article-title":"Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis","volume":"203","author":"Kraguljac","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2023.05.001_b0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbi.2022.03.016","article-title":"Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naive schizophrenia","volume":"103","author":"Lago","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2023.05.001_b0300","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra1801490","article-title":"Psychotic disorders","volume":"379","author":"Lieberman","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2023.05.001_b0210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.47102\/annals-acadmedsg.V33N3p320","article-title":"Interleukin-2 levels in chronic schizophrenia patients","volume":"33","author":"Mahendran","year":"2004","journal-title":"Ann. Acad. Med. Singap."},{"issue":"2-3","key":"10.1016\/j.bbi.2023.05.001_b0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2006.06.004","article-title":"T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment","volume":"152","author":"Maino","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2023.05.001_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-01991-7","article-title":"Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis","author":"Merritt","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.001_b0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","article-title":"Developmental neuroinflammation and schizophrenia","volume":"42","author":"Meyer","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2023.05.001_b0230","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2023.05.001_b0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiology.187.2.8475286","article-title":"Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy","volume":"187","author":"Miller","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.bbi.2023.05.001_b0240","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbi.2023.03.014","article-title":"Serum immune markers and transition to psychosis in individuals at clinical high risk","volume":"110","author":"Mondelli","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2023.05.001_b0245","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","article-title":"NK cells at the interface between innate and adaptive immunity","volume":"15","author":"Moretta","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbi.2023.05.001_b0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/B978-0-12-398314-5.00003-9","article-title":"Inflammation in schizophrenia","volume":"88","author":"Muller","year":"2012","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.bbi.2023.05.001_b0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000111535","article-title":"Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia","volume":"56","author":"Na","year":"2007","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.001_b0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2014.04.041","article-title":"Neuroinflammation and white matter pathology in schizophrenia: systematic review","volume":"161","author":"Najjar","year":"2015","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.001_b0265","doi-asserted-by":"crossref","first-page":"pyu042","DOI":"10.1093\/ijnp\/pyu042","article-title":"Effects of risperidone on cytokine profile in drug-naive first-episode psychosis","volume":"18","author":"Noto","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2023.05.001_b0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-1781(96)02824-7","article-title":"Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder","volume":"65","author":"O'Donnell","year":"1996","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.bbi.2023.05.001_b0275","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","article-title":"Glutamate-mediated excitotoxicity in schizophrenia: a review","volume":"24","author":"Plitman","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2023.05.001_b0280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: A proton magnetic resonance spectroscopy study with implications for glial dysfunction","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.001_b0285","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed."},{"key":"10.1016\/j.bbi.2023.05.001_b0290","article-title":"Cytokine imbalance in schizophrenia. From research to Clinic: Potential implications for treatment. Front","volume":"12","author":"Reale","year":"2021","journal-title":"Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2023.05.001_b0295","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12035-019-01737-z","article-title":"The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia","volume":"57","author":"Roomruangwong","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbi.2023.05.001_b0305","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00213-020-05504-0","article-title":"Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia","volume":"237","author":"Sahbaz","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.bbi.2023.05.001_b0310","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mp.2012.165","article-title":"Inflammatory and immune response genes have significantly altered expression in schizophrenia","volume":"18","author":"Sainz","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.001_b0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: Challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2023.05.001_b0320","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2022.12.017","article-title":"Increased rostral medial frontal GABA+ in early psychosis is obscured by levels of negative affect","volume":"252","author":"Simmonite","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2023.05.001_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716980","article-title":"Brain versus blood: A systematic review on the concordance between peripheral and central kynurenine pathway measures in psychiatric disorders","volume":"12","author":"Skorobogatov","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2023.05.001_b0330","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00406-010-0098-x","article-title":"Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity","volume":"260","author":"Steiner","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2023.05.001_b0335","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","article-title":"Glutamate and dopamine dysregulation in schizophrenia\u2013a synthesis and selective review","volume":"21","author":"Stone","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"1-3","key":"10.1016\/j.bbi.2023.05.001_b0340","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2015.10.038","article-title":"Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia","volume":"169","author":"Tan","year":"2015","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.bbi.2023.05.001_b0345","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1038\/s41380-020-01008-7","article-title":"Natural killer cells in first-episode psychosis: an innate immune signature?","volume":"26","author":"Tarantino","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2023.05.001_b0350","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Th\u00e9berge","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.05.001_b0355","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/erv.12.146","article-title":"T-cell-based immunotherapy of autoimmune diseases","volume":"12","author":"Ulivieri","year":"2013","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/j.bbi.2023.05.001_b0360","doi-asserted-by":"crossref","first-page":"e1075","DOI":"10.1038\/tp.2017.4","article-title":"Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies","volume":"7","author":"van Kesteren","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.001_b0365","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbi.2017.10.003","article-title":"Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients","volume":"67","author":"van Rees","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.05.001_b0370","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.schres.2020.05.044","article-title":"Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability","volume":"223","author":"Wang","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2023.05.001_b0375","first-page":"341","article-title":"Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls","volume":"27","author":"Yang","year":"2015","journal-title":"Shanghai Arch. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:36:13Z","timestamp":1762313773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159123001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":75,"alternative-id":["S0889159123001198"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2023.05.001","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}